Trial intelligence / Profile preview

DEXERYL for prevention of atopic dermatitis flares in children

2012-004621-24Phase 3Completed

Sponsor
Pierre Fabre Laboratories
Start
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of glycerol in atopic dermatitis (AD), sponsored by Pierre Fabre Laboratories. Primary endpoint: Percentage of patients with at least one flare over 12 weeks. Started Nov 2012; status: completed.

02

Drugs

glycerol
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on 2012-004621-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-004621-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call